Shelby Amey
Family · Stillwater, OKNPI 1962237396
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 160 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 11.4% — the pattern of someone who eats at a lot of different presentations.
Across 160 payments — averaging $18.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$340
- SK Life Science, Inc.$296
- AbbVie$276
- Neurocrine Biosciences, Inc.$273
- UCB, Inc.$265
- Argenx US, Inc.$264
- plus $1K from 15 others
What the payments were for
- Food & beverage$2,979100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 24 | $340 |
| SK Life Science, Inc. | 12 | $296 |
| AbbVie | 22 | $276 |
| Neurocrine Biosciences, Inc. | 16 | $273 |
| UCB, Inc. | 7 | $265 |
| Argenx US, Inc. | 12 | $264 |
| Pfizer | 20 | $237 |
| Merz Pharmaceuticals, LLC | 5 | $159 |
| Lundbeck LLC | 7 | $154 |
| Acadia Pharmaceuticals Inc | 8 | $150 |
| Genentech USA, Inc. | 6 | $124 |
| Bristol Myers Squibb | 4 | $80 |
| Vanda Pharmaceuticals Inc. | 3 | $73 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Eisai Inc. | 3 | $53 |
| AstraZeneca | 2 | $46 |
| Lilly USA, LLC | 2 | $46 |
| Medtronic | 1 | $27 |
| Averitas Pharma Inc. | 1 | $20 |
| Novo Nordisk | 1 | $20 |
| Biogen | 1 | $15 |
How this compares
$2,979 in reported general payments places this provider in the 85th percentile of 2,026 family providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 12 | $249 |
| Donepezil Hcl | 18 | $106 |
Paid to pharmacies, not to this prescriber.
Other family in Stillwater
- Shelby WrightStillwater$17K
- April WilcoxOklahoma City$245K
- Jeremy MorganOklahoma City$63K
- Samantha BellingerOklahoma City$39K
- Candy WilliamsTulsa$22K
- Lacey HillOklahoma City$20K
- Amanda OblanderYukon$17K
- Julia John SamuelOklahoma City$17K
- Jillian OakleafTulsa$15K
- Kristina SnyderOklahoma City$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.